Renin, angiotensin, and norepinephrine in alloxan diabetes.
D000804:Angiotensin II / Q000097:blood* / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D001810:Blood Volume / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000097:blood* / Q000517:prevention & control / Q000652:urine; D006400:Hematocrit; D007336:Insulin, Isophane / Q000627:therapeutic use; D007668:Kidney / Q000201:enzymology / Q000473:pathology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism* / Q000494:pharmacology; D011194:Potassium Isotopes; D011863:Radioimmunoassay; D011868:Radioisotopes; D051381:Rats; D012077:Renal Artery; D012083:Renin / Q000097:blood* / Q000378:metabolism; D013311:Streptozocin; D014439:Tyramine / Q000494:pharmacology
D001786:Blood Glucose; D011194:Potassium Isotopes; D011868:Radioisotopes; D000804:Angiotensin II; D007336:Insulin, Isophane; D013311:Streptozocin; D012083:Renin; D009638:Norepinephrine; D014439:Tyramine